BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang R, Miki K, Oksala N, Nakao A, Lindgren L, Killeen ME, Mennander A, Fink MP, Tenhunen J. Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia. Am J Physiol Regul Integr Comp Physiol. 2009;297:R362-R369. [PMID: 19494177 DOI: 10.1152/ajpregu.00184.2009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Gu L, Li N, Gong J, Li Q, Zhu W, Li J. Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J Infect Dis. 2011;203:1602-1612. [PMID: 21592990 DOI: 10.1093/infdis/jir147] [Cited by in Crossref: 104] [Cited by in F6Publishing: 89] [Article Influence: 9.5] [Reference Citation Analysis]
2 Caravaca AS, Levine YA, Drake A, Eberhardson M, Olofsson PS. Vagus Nerve Stimulation Reduces Indomethacin-Induced Small Bowel Inflammation. Front Neurosci 2022;15:730407. [DOI: 10.3389/fnins.2021.730407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chen X, Li L, Khan MN, Shi L, Wang Z, Zheng F, Gong F, Fang M. HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production. Innate Immun 2016;22:696-705. [DOI: 10.1177/1753425916669862] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
4 Zhu S, Li W, Ward MF, Sama AE, Wang H. High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation. Inflamm Allergy Drug Targets 2010;9:60-72. [PMID: 19906009 DOI: 10.2174/187152810791292872] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
5 Li MX, Liu JF, Lu JD, Zhu Y, Kuang DW, Xiang JB, Sun P, Wang W, Xue J, Gu Y, Hao CM. Plasmadiafiltration ameliorating gut mucosal barrier dysfunction and improving survival in porcine sepsis models. Intensive Care Med Exp 2016;4:31. [PMID: 27682607 DOI: 10.1186/s40635-016-0105-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
6 Li X, Mazaleuskaya LL, Ballantyne LL, Meng H, FitzGerald GA, Funk CD. Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice. J Lipid Res 2018;59:102-12. [PMID: 29180443 DOI: 10.1194/jlr.M080028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
7 Sun X, Zhu S, Tonnessen TI, Yang R. Bile is a promising gut nutrient that inhibits intestinal bacterial translocation and promotes gut motility via an interleukin-6-related pathway in an animal model of endotoxemia. Nutrition 2021;84:111064. [PMID: 33418232 DOI: 10.1016/j.nut.2020.111064] [Reference Citation Analysis]
8 Chen X, Zhao HX, Bai C, Zhou XY. Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis. Sci Rep. 2017;7:6799. [PMID: 28754974 DOI: 10.1038/s41598-017-07094-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
9 Yang R, Tenhunen J, Tonnessen TI. HMGB1 and Histones Play a Significant Role in Inducing Systemic Inflammation and Multiple Organ Dysfunctions in Severe Acute Pancreatitis. Int J Inflam. 2017;2017:1817564. [PMID: 28316860 DOI: 10.1155/2017/1817564] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
10 Zhang D, Qiu W, Wang P, Zhang P, Zhang F, Wang P, Sun Y. Autophagy can alleviate severe burn-induced damage to the intestinal tract in mice. Surgery 2017;162:408-17. [PMID: 28624177 DOI: 10.1016/j.surg.2017.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
11 Xu YF, Liu ZL, Pan C, Yang XQ, Ning SL, Liu HD, Guo S, Yu JM, Zhang ZL. HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium. Oncogene 2019;38:868-80. [PMID: 30177842 DOI: 10.1038/s41388-018-0485-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
12 Yue C, Wang W, Tian WL, Huang Q, Zhao RS, Zhao YZ, Li QR, Li JS. Lipopolysaccharide-induced failure of the gut barrier is site-specific and inhibitable by growth hormone. Inflamm Res. 2013;62:407-415. [PMID: 23340865 DOI: 10.1007/s00011-013-0593-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
13 Nadatani Y, Watanabe T, Tanigawa T, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Arakawa T. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4. Am J Pathol. 2012;181:98-110. [PMID: 22634181 DOI: 10.1016/j.ajpath.2012.03.039] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
14 Li G, Zhou CL, Zhou QS, Zou HD. Galantamine protects against lipopolysaccharide-induced acute lung injury in rats. Braz J Med Biol Res. 2016;49:e5008. [PMID: 26648090 DOI: 10.1590/1414-431x20155008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
15 Hagiwara S, Iwasaka H, Kusaka J, Asai N, Uchida T, Noguchi T. Total parenteral-nutrition-mediated dendritic-cell activation and infiltration into the small intestine in a rat model. J Anesth 2011;25:57-64. [PMID: 21057821 DOI: 10.1007/s00540-010-1037-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
16 Kumagai M, Ishii M, Morimoto K, Tomita M. Increased membrane permeation and blood concentration of 6-carboxyfluorescein associated with dysfunction of paracellular route barrier in the small intestine of ulcerative colitis model rats. Biopharm Drug Dispos 2020;41:91-100. [PMID: 32043274 DOI: 10.1002/bdd.2220] [Reference Citation Analysis]
17 Fredenburgh LE, Velandia MM, Ma J, Olszak T, Cernadas M, Englert JA, Chung SW, Liu X, Begay C, Padera RF, Blumberg RS, Walsh SR, Baron RM, Perrella MA. Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis. J Immunol 2011;187:5255-67. [PMID: 21967897 DOI: 10.4049/jimmunol.1101186] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
18 Wang F, Wen Q, Zhang S, Fu Z, Liu F, Cui J, Liu J, Tian H. Sustained bile drainage decreases the organs injuries via inflammation-associated factors modulation in a severe acute pancreatitis rat model. Exp Ther Med 2019;17:4628-34. [PMID: 31086593 DOI: 10.3892/etm.2019.7478] [Reference Citation Analysis]
19 Tourneur E, Chassin C. Neonatal immune adaptation of the gut and its role during infections. Clin Dev Immunol. 2013;2013:270301. [PMID: 23737810 DOI: 10.1155/2013/270301] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
20 Li Z, Zhang X, Zhou H, Liu W, Li J. Exogenous S-nitrosoglutathione attenuates inflammatory response and intestinal epithelial barrier injury in endotoxemic rats. J Trauma Acute Care Surg 2016;80:977-84. [PMID: 26891162 DOI: 10.1097/TA.0000000000001008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
21 Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139-162. [PMID: 21219181 DOI: 10.1146/annurev-immunol-030409-101323] [Cited by in Crossref: 881] [Cited by in F6Publishing: 852] [Article Influence: 80.1] [Reference Citation Analysis]
22 Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, Sun X, Wang H, Wang Q, Tsung A, Billiar TR, Zeh HJ 3rd, Lotze MT, Tang D. HMGB1 in health and disease. Mol Aspects Med 2014;40:1-116. [PMID: 25010388 DOI: 10.1016/j.mam.2014.05.001] [Cited by in Crossref: 445] [Cited by in F6Publishing: 443] [Article Influence: 55.6] [Reference Citation Analysis]
23 Yang H, Tracey KJ. Targeting HMGB1 in inflammation. Biochim Biophys Acta. 2010;1799:149-156. [PMID: 19948257 DOI: 10.1016/j.bbagrm.2009.11. 019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Yang H, Tracey KJ. Targeting HMGB1 in inflammation. Biochim Biophys Acta. 2010;1799:149-156. [PMID: 19948257 DOI: 10.1016/j.bbagrm.2009.11.019] [Cited by in Crossref: 224] [Cited by in F6Publishing: 231] [Article Influence: 17.2] [Reference Citation Analysis]
25 Farina A, Delhaye M, Lescuyer P, Dumonceau JM. Bile proteome in health and disease. Compr Physiol 2014;4:91-108. [PMID: 24692135 DOI: 10.1002/cphy.c130016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
26 Gaskell H, Ge X, Desert R, Das S, Han H, Lantvit D, Guzman G, Nieto N. Ablation of Hmgb1 in Intestinal Epithelial Cells Causes Intestinal Lipid Accumulation and Reduces NASH in Mice. Hepatol Commun 2020;4:92-108. [PMID: 31909358 DOI: 10.1002/hep4.1448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Gao DD, Fu J, Qin B, Huang WX, Yang C, Jia B. Recombinant adenovirus containing hyper-interleukin-6 and hepatocyte growth factor ameliorates acute-on-chronic liver failure in rats. World J Gastroenterol 2016; 22(16): 4136-4148 [PMID: 27122664 DOI: 10.3748/wjg.v22.i16.4136] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Bateman SL, Seed PC. Procession to pediatric bacteremia and sepsis: covert operations and failures in diplomacy. Pediatrics 2010;126:137-50. [PMID: 20566606 DOI: 10.1542/peds.2009-3169] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
29 Deng M, Scott MJ, Fan J, Billiar TR. Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation. J Leukoc Biol 2019;106:161-9. [PMID: 30946496 DOI: 10.1002/JLB.3MIR1218-497R] [Cited by in Crossref: 18] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
30 Yang R, Zou X, Tenhunen J, Zhu S, Kajander H, Koskinen ML, Tonnessen TI. HMGB1 neutralization is associated with bacterial translocation during acetaminophen hepatotoxicity. BMC Gastroenterol. 2014;14:66. [PMID: 24708589 DOI: 10.1186/1471-230x-14-66] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
31 Yang R, Zhu S, Pischke SE, Haugaa H, Zou X, Tonnessen TI. Bile and circulating HMGB1 contributes to systemic inflammation in obstructive jaundice. J Surg Res 2018;228:14-9. [PMID: 29907203 DOI: 10.1016/j.jss.2018.02.049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
32 Chen X, Fu Y, Wang L, Qian W, Zheng F, Hou X. Bifidobacterium longum and VSL#3® amelioration of TNBS-induced colitis associated with reduced HMGB1 and epithelial barrier impairment. Developmental & Comparative Immunology 2019;92:77-86. [DOI: 10.1016/j.dci.2018.09.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
33 Kumar V, Mansfield J, Fan R, MacLean A, Li J, Mohan M. miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques. J Immunol 2018;200:2677-89. [PMID: 29514950 DOI: 10.4049/jimmunol.1701148] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
34 Yang R, Zou X, Tenhunen J, Tønnessen TI. HMGB1 and Extracellular Histones Significantly Contribute to Systemic Inflammation and Multiple Organ Failure in Acute Liver Failure. Mediators Inflamm 2017;2017:5928078. [PMID: 28694564 DOI: 10.1155/2017/5928078] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
35 Costantini TW, Krzyzaniak M, Cheadle GA, Putnam JG, Hageny AM, Lopez N, Eliceiri BP, Bansal V, Coimbra R. Targeting α-7 nicotinic acetylcholine receptor in the enteric nervous system: a cholinergic agonist prevents gut barrier failure after severe burn injury. Am J Pathol. 2012;181:478-486. [PMID: 22688057 DOI: 10.1016/j.ajpath.2012.04.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
36 Li X, Wang LK, Wang LW, Han XQ, Yang F, Gong ZJ. Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats. Inflamm Res. 2013;62:703-709. [PMID: 23591781 DOI: 10.1007/s00011-013-0624-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
37 Vitali R, Stronati L, Negroni A, Di Nardo G, Pierdomenico M, del Giudice E, Rossi P, Cucchiara S. Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease. Am J Gastroenterol. 2011;106:2029-2040. [PMID: 21788990 DOI: 10.1038/ajg.2011.231] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 6.9] [Reference Citation Analysis]
38 Yang C, Song HW, Liu W, Dong XS, Liu Z. Protective Effects of Chymostatin on Paraquat-Induced Acute Lung Injury in Mice. Inflammation 2018;41:122-33. [PMID: 28940034 DOI: 10.1007/s10753-017-0670-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
39 Short SS, Wang J, Castle SL, Fernandez GE, Smiley N, Zobel M, Pontarelli EM, Papillon SC, Grishin AV, Ford HR. Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis. Lab Invest 2013;93:1265-75. [PMID: 24126890 DOI: 10.1038/labinvest.2013.119] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
40 Khazoom F, L'Écuyer S, Gilbert K, Gagné MA, Bouchard C, Rose CF, Rousseau G, Charbonney E. Impact of uric acid on liver injury and intestinal permeability following resuscitated hemorrhagic shock in rats. J Trauma Acute Care Surg 2020;89:1076-84. [PMID: 33231951 DOI: 10.1097/TA.0000000000002868] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Li X, Wu Y, Zhang W, Gong J, Cheng Y. Pre-conditioning with tanshinone IIA attenuates the ischemia/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells. Biomed Pharmacother 2017;89:1392-400. [PMID: 28320107 DOI: 10.1016/j.biopha.2017.03.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]